Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan from 2000 to 2006

Stevens, 1922, A new eruptive fever associated with stomatitis and opthalmia, Am. J. Dis. Child., 24, 526, 10.1001/archpedi.1922.04120120077005

Lyell, 1956, Toxic epidermal necrolysis: an eruption resembling scalding of the skin, Br. J. Dermatol., 68, 355, 10.1111/j.1365-2133.1956.tb12766.x

Bastuji-Garin, 1993, Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme, Arch. Dermatol., 129, 92, 10.1001/archderm.1993.01680220104023

Schopf, 1991, Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany, Arch. Dermatol., 127, 839, 10.1001/archderm.1991.01680050083008

Roujeau, 1994, The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification, J. Invest. Dermatol., 102, 28S, 10.1111/1523-1747.ep12388434

Roujeau, 1997, Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme, J. Dermatol., 24, 726, 10.1111/j.1346-8138.1997.tb02524.x

Paul, 1996, Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis, Br. J. Dermatol., 134, 710, 10.1111/j.1365-2133.1996.tb06976.x

Caproni, 2006, Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis, Br. J. Dermatol., 155, 722, 10.1111/j.1365-2133.2006.07398.x

Abe, 2003, Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand, Am. J. Pathol., 162, 1515, 10.1016/S0002-9440(10)64284-8

Viard, 1998, Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin, Science, 282, 490, 10.1126/science.282.5388.490

Garcia-Doval, 2000, Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?, Arch. Dermatol., 136, 323327, 10.1001/archderm.136.3.323

Mockenhaupt, 1996, Epidemiology of drug-induced severe skin reactions, Semin. Cutan. Med. Surg., 15, 236, 10.1016/S1085-5629(96)80036-8

Ghislain, 2002, Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome, Dermatol. Online J., 8, 5, 10.5070/D397D8T291

French, 2006, Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding, Int. Immunopharmacol., 6, 543, 10.1016/j.intimp.2005.11.012

Prins, 2003, TEN-IVIG Study Group. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases, Arch. Dermatol., 139, 26, 10.1001/archderm.139.1.26

Kim, 2005, Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients, Acta Derm. Venereol., 85, 497, 10.1080/00015550510038232

Bamichas, 2002, Plasma exchange in patients with toxic epidermal necrolysis, Ther. Apher., 6, 225, 10.1046/j.1526-0968.2002.00409.x

Egan, 1999, Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis, J. Am. Acad. Dermatol., 40, 458, 10.1016/S0190-9622(99)70497-4

Kamanabroo, 1985, Plasmapheresis in severe drug-induced toxic epidermal necrolysis, Arch. Dermatol., 121, 1548, 10.1001/archderm.1985.01660120074023

Letko, 2005, Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature, Ann. Allergy Asthma Immunol, 94, 419, 10.1016/S1081-1206(10)61112-X

Aihara, 1999, Clinical study of deceased cases of Toxic epidermal necrolysis (TEN) in Japan; Comparative study with surviving cases of TEN and with deceased cases of Stevens-Johnson syndrome, Jpn. J. Dermatol., 109, 1581

Kim, 1983, Stevens Johnson syndrome and toxic epidermal necrolysis: A pathophysiologic review with recommendations for a treatment protocol, J. Burn. Care Rehabil., 4, 91, 10.1097/00004630-198303000-00003

Halebian, 1986, Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids, Ann. Surg., 204, 503, 10.1097/00000658-198611000-00001

Murphy, 1997, Toxic epidermal necrolysis, J. Burn. CareRehabil., 18, 417

Tripathi, 2000, Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases, Allergy Asthma Proc., 21, 101, 10.2500/108854100778250914

Moncada, 1994, Abnormal T-cell response in toxic epidermal necrolysis, Arch. Dermatol., 130, 116, 10.1001/archderm.1994.01690010122026

Parsons, 1985, Management of toxic epidermal necrolysis, Cutis., 36, 305

Sherertz, 1985, Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy", J. Am. Acad. Dermatol., 12, 178, 10.1016/S0190-9622(85)80012-8